<DOC>
	<DOC>NCT00114023</DOC>
	<brief_summary>This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.</brief_summary>
	<brief_title>1-Year Follow up to the 1473-IMIQ Study</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Subject had to participate in the 1473IMIQ Study AND have had 100% clearance of AK lesions Did not use any topical preparations in the previous treatment area within 24hours of the scheduled visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>AK</keyword>
	<keyword>Imiquimod 5% cream</keyword>
	<keyword>3M Pharmaceuticals</keyword>
	<keyword>Aldara</keyword>
	<keyword>Actinic Keratosis</keyword>
</DOC>